2-Phenyl-2-(1-piperidinyl)propane

2-Phenyl-2-(1-piperidinyl)propane (CAS No.: 92321-29-4) is a synthetic small-molecule inhibitor belonging to the class of piperidine-containing compounds and is widely used as a biochemical tool for investigating cytochrome P450-mediated drug metabolism, particularly the CYP2B6 isoform. It functions as a selective, mechanism-based inactivator of CYP2B6, exhibiting inhibitory activity in the low micromolar range and demonstrating substantially greater selectivity toward CYP2B6 compared with other major drug-metabolizing enzymes, including CYP2D6, CYP1A2, CYP2A6, CYP2C subfamily members, and CYP3A. In vitro studies have shown that its inhibitory effects are time- and concentration-dependent and require NADPH, consistent with mechanism-based inactivation kinetics that involve modification of the enzyme apoprotein rather than heme destruction. The compound effectively suppresses catalytic activities such as O-dealkylation reactions in liver microsomes and recombinant enzyme systems, making it a valuable probe for dissecting CYP2B6-specific contributions in xenobiotic metabolism and drug–drug interaction studies. Due to the limited availability of highly selective CYP2B6 inhibitors, this compound is frequently employed in enzyme phenotyping assays, metabolic pathway elucidation, and preclinical screening workflows. Experimental concentrations typically fall within the micromolar range, depending on assay design and biological system, while in vivo and clinical data remain limited, underscoring its primary utility as an in vitro research reagent in pharmacokinetic and drug discovery investigations.